On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 2016/2017 providing an overview of administration under the Patented Medicines (Notice of Compliance) Regulations and Data Protection. The report includes information regarding trends in listing on the Patent Register and Register of Innovative Drugs, as well as related court activity. The Report shows an upward trend of new patent listings on the Patent Register (769 in 2016/17 compared to 644 in 2015/16) and a decline in new human drug listings on the Register of Innovative Drugs (31 in 2016/17 compared to 40 in 2015/16). The number of prohibition applications substantially increased from 18 in 2015/2016 to 32 in 2016/2017 (as of March 31, 2017).